Perceived or Calculated Bleeding Risk and Their Relation With Dual Antiplatelet Therapy Duration in Patients Undergoing Percutaneous Coronary Intervention

Circ Cardiovasc Interv. 2019 Jun;12(6):e007949. doi: 10.1161/CIRCINTERVENTIONS.119.007949. Epub 2019 May 30.
No abstract available

Keywords: clopidogrel; coronary artery disease; hemorrhage; percutaneous coronary intervention; prasugrel hydrochloride; ticagrelor.

Publication types

  • Letter
  • Multicenter Study
  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Clinical Decision-Making
  • Coronary Artery Disease / therapy*
  • Decision Support Techniques*
  • Drug Therapy, Combination
  • Hemorrhage / chemically induced*
  • Humans
  • Italy
  • Percutaneous Coronary Intervention / adverse effects*
  • Platelet Aggregation Inhibitors / administration & dosage
  • Platelet Aggregation Inhibitors / adverse effects*
  • Practice Patterns, Physicians'*
  • Predictive Value of Tests
  • Registries
  • Risk Assessment
  • Risk Factors
  • Treatment Outcome

Substances

  • Platelet Aggregation Inhibitors